WallStreetZenWallStreetZen

NASDAQ: NUTX
Nutex Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NUTX

Based on 3 analysts offering 12 month price targets for Nutex Health Inc

Min Forecast
$290.00+38.88%
Avg Forecast
$308.33+47.65%
Max Forecast
$325.00+55.64%

Should I buy or sell NUTX stock?

Based on 3 analysts offering ratings for Nutex Health Inc.

Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NUTX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NUTX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their NUTX stock forecasts and price targets.

NUTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-04Find Out Why
lockedlocked$00.00+00.00%2026-08-11
lockedlocked$00.00+00.00%2026-06-26

1 of 1

Forecast return on equity

Is NUTX forecast to generate an efficient return?

Company
44.89%
Industry
16.52%
Market
148.48%
NUTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NUTX forecast to generate an efficient return on assets?

Company
18.35%
Industry
12.4%
NUTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NUTX earnings per share forecast

What is NUTX's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$28.35+8.83%
Avg 2 year Forecast
$28.43+9.13%
Avg 3 year Forecast
$25.85-0.78%
NUTX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

NUTX revenue forecast

What is NUTX's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$889.5M+5.05%
Avg 2 year Forecast
$983.5M+16.15%
Avg 3 year Forecast
$1.0B+22.12%
NUTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NUTX earnings growth forecast

How is NUTX forecast to perform vs Health Information Services companies and vs the US market?

Company
3.12%
Industry
24.32%
Market
63.28%
NUTX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NUTX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NUTX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NUTX revenue growth forecast

How is NUTX forecast to perform vs Health Information Services companies and vs the US market?

Company
7.12%
Industry
7.72%
Market
15.38%
NUTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NUTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NUTX vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
NUTX$208.82$308.33+47.65%Strong Buy
OMCL$33.17$53.33+60.79%Strong Buy
CERT$8.83$7.79-11.82%Buy
OMDA$21.37$27.58+29.07%Strong Buy
GDRX$3.44$4.55+32.27%Buy
View Top Health Information Service Stocks

Nutex Health Stock Forecast FAQ

Is Nutex Health Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: NUTX) stock is to Strong Buy NUTX stock.

Out of 3 analysts, 3 (100%) are recommending NUTX as a Strong Buy, 0 (0%) are recommending NUTX as a Buy, 0 (0%) are recommending NUTX as a Hold, 0 (0%) are recommending NUTX as a Sell, and 0 (0%) are recommending NUTX as a Strong Sell.

If you're new to stock investing, here's how to buy Nutex Health stock.

What is NUTX's earnings growth forecast for 2026-2028?

(NASDAQ: NUTX) Nutex Health's forecast annual earnings growth rate of 3.12% is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 24.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 63.28%.

Nutex Health's earnings in 2026 is $179,918,000.On average, 7 Wall Street analysts forecast NUTX's earnings for 2026 to be $194,139,350, with the lowest NUTX earnings forecast at $171,533,506, and the highest NUTX earnings forecast at $211,325,023. On average, 7 Wall Street analysts forecast NUTX's earnings for 2027 to be $194,683,764, with the lowest NUTX earnings forecast at $166,768,686, and the highest NUTX earnings forecast at $220,816,313.

In 2028, NUTX is forecast to generate $176,998,189 in earnings, with the lowest earnings forecast at $170,057,083 and the highest earnings forecast at $182,204,018.

What is NUTX's revenue growth forecast for 2026-2028?

(NASDAQ: NUTX) Nutex Health's forecast annual revenue growth rate of 7.12% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.38%.

Nutex Health's revenue in 2026 is $846,720,000.On average, 7 Wall Street analysts forecast NUTX's revenue for 2026 to be $6,090,998,065, with the lowest NUTX revenue forecast at $5,814,819,313, and the highest NUTX revenue forecast at $6,349,098,167. On average, 7 Wall Street analysts forecast NUTX's revenue for 2027 to be $6,734,844,486, with the lowest NUTX revenue forecast at $6,288,219,687, and the highest NUTX revenue forecast at $7,197,219,623.

In 2028, NUTX is forecast to generate $7,080,804,082 in revenue, with the lowest revenue forecast at $6,806,200,365 and the highest revenue forecast at $7,293,091,245.

What is NUTX's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: NUTX) forecast ROA is 18.35%, which is higher than the forecast US Health Information Services industry average of 12.4%.

What is NUTX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year NUTX price target, the average NUTX price target is $308.33, with the highest NUTX stock price forecast at $325.00 and the lowest NUTX stock price forecast at $290.00.

On average, Wall Street analysts predict that Nutex Health's share price could reach $308.33 by Sep 4, 2027. The average Nutex Health stock price prediction forecasts a potential upside of 47.65% from the current NUTX share price of $208.82.

What is NUTX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: NUTX) Nutex Health's current Earnings Per Share (EPS) is $26.05. On average, analysts forecast that NUTX's EPS will be $28.35 for 2026, with the lowest EPS forecast at $25.05, and the highest EPS forecast at $30.86. On average, analysts forecast that NUTX's EPS will be $28.43 for 2027, with the lowest EPS forecast at $24.35, and the highest EPS forecast at $32.25. In 2028, NUTX's EPS is forecast to hit $25.85 (min: $24.83, max: $26.61).

What is NUTX's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: NUTX) forecast ROE is 44.89%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.